Burk Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Burk Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.4K	Hold	45	–	–	0.01%	199
2026 Q1	$20.1K	Buy	+45	New	+$21K	0.01%	199

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Burk Holdings's VRTX Position: Q2 2026 in Review

Burk Holdings held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 45 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #199.

Burk Holdings first reported a position in VRTX in Q1 2026 and has held it in 2 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Burk Holdings held 45 shares of Vertex Pharmaceuticals worth $22.4K as of Q2 2026.
Burk Holdings left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.01% of Burk Holdings's portfolio in Q2 2026, its #199 holding.
Burk Holdings first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Burk Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.